These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Evaluation of amniotic membrane transplantation as an adjunct to medical therapy as compared with medical therapy alone in acute ocular burns. Tamhane A; Vajpayee RB; Biswas NR; Pandey RM; Sharma N; Titiyal JS; Tandon R Ophthalmology; 2005 Nov; 112(11):1963-9. PubMed ID: 16198422 [TBL] [Abstract][Full Text] [Related]
24. Corneal fluorescein staining correlates with visual function in dry eye patients. Kaido M; Matsumoto Y; Shigeno Y; Ishida R; Dogru M; Tsubota K Invest Ophthalmol Vis Sci; 2011 Dec; 52(13):9516-22. PubMed ID: 22110071 [TBL] [Abstract][Full Text] [Related]
25. The effect of treatment and its related side effects in patients with severe ocular cicatricial pemphigoid. Miserocchi E; Baltatzis S; Roque MR; Ahmed AR; Foster CS Ophthalmology; 2002 Jan; 109(1):111-8. PubMed ID: 11772589 [TBL] [Abstract][Full Text] [Related]
26. Safety and efficacy of cyclosporine 0.05% drops versus unpreserved artificial tears in dry-eye patients having laser in situ keratomileusis. Salib GM; McDonald MB; Smolek M J Cataract Refract Surg; 2006 May; 32(5):772-8. PubMed ID: 16765793 [TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease: a dose-ranging, randomized trial. The Cyclosporin A Phase 2 Study Group. Stevenson D; Tauber J; Reis BL Ophthalmology; 2000 May; 107(5):967-74. PubMed ID: 10811092 [TBL] [Abstract][Full Text] [Related]
29. Diurnal variation of visual function and the signs and symptoms of dry eye. Walker PM; Lane KJ; Ousler GW; Abelson MB Cornea; 2010 Jun; 29(6):607-12. PubMed ID: 20458235 [TBL] [Abstract][Full Text] [Related]
30. Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group. Sall K; Stevenson OD; Mundorf TK; Reis BL Ophthalmology; 2000 Apr; 107(4):631-9. PubMed ID: 10768324 [TBL] [Abstract][Full Text] [Related]
31. Evaluation of umbilical cord serum therapy in acute ocular chemical burns. Sharma N; Goel M; Velpandian T; Titiyal JS; Tandon R; Vajpayee RB Invest Ophthalmol Vis Sci; 2011 Feb; 52(2):1087-92. PubMed ID: 20538982 [TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety of treatment of hyposecretory dry eye with platelet-rich plasma. García-Conca V; Abad-Collado M; Hueso-Abancens JR; Mengual-Verdú E; Piñero DP; Aguirre-Balsalobre F; Molina JC Acta Ophthalmol; 2019 Mar; 97(2):e170-e178. PubMed ID: 30450721 [TBL] [Abstract][Full Text] [Related]
33. Scleral lenses in the management of ocular surface disease. Schornack MM; Pyle J; Patel SV Ophthalmology; 2014 Jul; 121(7):1398-405. PubMed ID: 24630687 [TBL] [Abstract][Full Text] [Related]
35. Corneal surface regularity and the effect of artificial tears in aqueous tear deficiency. Liu Z; Pflugfelder SC Ophthalmology; 1999 May; 106(5):939-43. PubMed ID: 10328393 [TBL] [Abstract][Full Text] [Related]
36. Evaluation of the clinical course of dry eye syndrome. Horwath-Winter J; Berghold A; Schmut O; Floegel I; Solhdju V; Bodner E; Schwantzer G; Haller-Schober EM Arch Ophthalmol; 2003 Oct; 121(10):1364-8. PubMed ID: 14557170 [TBL] [Abstract][Full Text] [Related]
37. Extended-wear silicone hydrogel soft contact lenses in the management of moderate to severe dry eye signs and symptoms secondary to graft-versus-host disease. Russo PA; Bouchard CS; Galasso JM Eye Contact Lens; 2007 May; 33(3):144-7. PubMed ID: 17502749 [TBL] [Abstract][Full Text] [Related]
38. The modified Cincinnati procedure: combined conjunctival limbal autografts and keratolimbal allografts for severe unilateral ocular surface failure. Chan CC; Biber JM; Holland EJ Cornea; 2012 Nov; 31(11):1264-72. PubMed ID: 22406944 [TBL] [Abstract][Full Text] [Related]
39. Patient-reported outcomes of autologous serum tears for the treatment of dry eye disease in a large cohort. Kreimei M; Sorkin N; Boutin T; Slomovic AR; Rootman DS; Chan CC Ocul Surf; 2019 Oct; 17(4):743-746. PubMed ID: 31276828 [TBL] [Abstract][Full Text] [Related]
40. Autologous serum eye drops for the treatment of persistent corneal epithelial defects. Arain MA; Dar AJ; Adeeb L J Coll Physicians Surg Pak; 2013 Oct; 23(10):737-9. PubMed ID: 24112261 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]